Literature DB >> 28093820

Synthesis of 2,2,2,-Trichloroethyl Aryl- and Vinyldiazoacetates by Palladium-Catalyzed Cross-Coupling.

Liangbing Fu1, Jeffrey D Mighion1, Eric A Voight2, Huw M L Davies1.   

Abstract

An efficient and convenient synthesis of 2,2,2-trichloroethyl (TCE) aryl- and vinyldiazoacetates was achieved by palladium-catalyzed cross-coupling reactions between TCE diazoacetates and aryl or vinyl iodides. The broad substrate scope allows for rapid and facile formation of TCE aryl- and vinyldiazoacetates, which recently have emerged as versatile reagents for rhodium-carbene chemistry.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  asymmetric cyclopropanation; cross-coupling; diazoacetates; donor/acceptor carbenes; palladium

Year:  2017        PMID: 28093820     DOI: 10.1002/chem.201700101

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  4 in total

1.  Regio- and Stereoselective Rhodium(II)-Catalyzed C-H Functionalization of Cyclobutanes.

Authors:  Zachary J Garlets; Benjamin D Wertz; Wenbin Liu; Eric A Voight; Huw M L Davies
Journal:  Chem       Date:  2020-01-09       Impact factor: 22.804

2.  Regio- and Stereoselective Rhodium(II)-Catalyzed C-H Functionalization of Organosilanes by Donor/Acceptor Carbenes Derived from Aryldiazoacetates.

Authors:  Zachary J Garlets; Elliot F Hicks; Jiantao Fu; Eric A Voight; Huw M L Davies
Journal:  Org Lett       Date:  2019-06-11       Impact factor: 6.005

3.  Finding Opportunities from Surprises and Failures. Development of Rhodium-Stabilized Donor/Acceptor Carbenes and Their Application to Catalyst-Controlled C-H Functionalization.

Authors:  Huw M L Davies
Journal:  J Org Chem       Date:  2019-10-10       Impact factor: 4.354

4.  Asymmetric Radical Process for General Synthesis of Chiral Heteroaryl Cyclopropanes.

Authors:  Xiaoxu Wang; Jing Ke; Yiling Zhu; Arghya Deb; Yijie Xu; X Peter Zhang
Journal:  J Am Chem Soc       Date:  2021-07-20       Impact factor: 16.383

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.